3-(4-[N(ALPHA)-TERT.-BUTOXYCARBONYL-L-LEUCINOYLAMINO]-PHENYL)-PROPANOIC-ACID-METHYLESTER
Compound with spectra: 1 NMR
![3-(4-[N(ALPHA)-TERT.-BUTOXYCARBONYL-L-LEUCINOYLAMINO]-PHENYL)-PROPANOIC-ACID-METHYLESTER](/api/compound/ejKwwKOecB.png?ph=true&h=300&w=458 "3-(4-[N(ALPHA)-TERT.-BUTOXYCARBONYL-L-LEUCINOYLAMINO]-PHENYL)-PROPANOIC-ACID-METHYLESTER")
| SpectraBase Compound ID | ejKwwKOecB |
|---|---|
| InChI | InChI=1S/C21H32N2O5/c1-14(2)13-17(23-20(26)28-21(3,4)5)19(25)22-16-10-7-15(8-11-16)9-12-18(24)27-6/h7-8,10-11,14,17H,9,12-13H2,1-6H3,(H,22,25)(H,23,26)/t17-/m0/s1 |
| InChIKey | JMHKOBYSHHQUMF-KRWDZBQOSA-N |
| Mol Weight | 392.5 g/mol |
| Molecular Formula | C21H32N2O5 |
| Exact Mass | 392.231122 g/mol |
| Enantiomer InChIKey | JMHKOBYSHHQUMF-QGZVFWFLSA-N |
| Racemate InChIKey | JMHKOBYSHHQUMF-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-(4-[N(ALPHA)-TERT.-BUTOXYCARBONYL-L-LEUCINOYLAMINO]-PHENYL)-PROPANOIC-ACID
benzyl 4-amino-1-(anilinocarbonyl)-4-oxobutylcarbamate
tert-Butyl (S)-{6-Amino-1-[(2,2-diphenylethyl)amino]-1-oxo-hexan-2-yl}carbamate
tert-Butyl (R)-{6-Amino-1-[(2,2-diphenylethyl)amino]-1-oxo-hexan-2-yl}carbamate
(2S)-2-[(4,4-DIMETHYL-3-OXOPENTYL)-AMINO]-N-(4-METHYLPHENYL)-3-PHENYLPROPANAMIDE
T-Butoxycarbonyl-lysyl(T-butoxycarbonyl)-glycine benzyl ester
N-[(1S)-1-benzyl-2-(benzylamino)-2-keto-ethyl]carbamic acid tert-butyl ester
N-[(1S)-1-benzyl-2-(cyclohexylamino)-2-keto-ethyl]carbamic acid tert-butyl ester
Benzenepropanamide, N-(2-hydroxy-1-cyanoethyl)-.alpha.-(t-butoxycarbonylamino)-
2-[[2-(tert-butoxycarbonylamino)-3-phenyl-propanoyl]amino]acetic acid [(E)-but-2-enyl] ester
| Title | Journal or Book | Year |
|---|---|---|
| Design, Synthesis, and Pharmacological Evaluation of Thapsigargin Analogues for Targeting Apoptosis to Prostatic Cancer Cells | Journal of Medicinal Chemistry | 2001 |